Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with recurrent variceal hemorrhage.

Peter P, Andrej Z, Katarina SP, Manca G, Pavel S.

Gastroenterol Res Pract. 2013;2013:398172. doi: 10.1155/2013/398172. Epub 2013 Mar 28.

2.

Transjugular intrahepatic portosystemic shunt vs endoscopic therapy in preventing variceal rebleeding.

Xue H, Zhang M, Pang JX, Yan F, Li YC, Lv LS, Yuan J, Palikhe M, Li WZ, Wang ZL.

World J Gastroenterol. 2012 Dec 28;18(48):7341-7. doi: 10.3748/wjg.v18.i48.7341.

3.

Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.

Sahagun G, Benner KG, Saxon R, Barton RE, Rabkin J, Keller FS, Rosch J.

Am J Gastroenterol. 1997 Sep;92(9):1444-52.

PMID:
9317060
5.

Transjugular Intrahepatic Portosystemic Shunt for Extrahepatic Portal Venous Obstruction in Children.

Lv Y, He C, Guo W, Yin Z, Wang J, Zhang B, Meng X, Cai J, Luo B, Wu F, Niu J, Fan D, Han G.

J Pediatr Gastroenterol Nutr. 2016 Feb;62(2):233-41. doi: 10.1097/MPG.0000000000000982.

PMID:
26381818
6.

Increase in hepatic arterial blood flow after transjugular intrahepatic portosystemic shunt creation and its potential predictive value of postprocedural encephalopathy and mortality.

Patel NH, Sasadeusz KJ, Seshadri R, Chalasani N, Shah H, Johnson MS, Namyslowski J, Moresco KP, Trerotola SO.

J Vasc Interv Radiol. 2001 Nov;12(11):1279-84.

PMID:
11698626
7.

Emergent salvage direct intrahepatic portocaval shunt procedure for acute variceal hemorrhage.

Ward TJ, Techasith T, Louie JD, Hwang GL, Hofmann LV, Sze DY.

J Vasc Interv Radiol. 2015 Jun;26(6):829-34. doi: 10.1016/j.jvir.2015.03.004. Epub 2015 Apr 14.

PMID:
25881512
8.

The presence of spontaneous portosystemic shunts increases the risk of complications after transjugular intrahepatic portosystemic shunt (TIPS) placement.

Borentain P, Soussan J, Resseguier N, Botta-Fridlund D, Dufour JC, Gérolami R, Vidal V.

Diagn Interv Imaging. 2016 Jun;97(6):643-50. doi: 10.1016/j.diii.2016.02.004. Epub 2016 Mar 2.

9.

Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts.

Riggio O, Angeloni S, Salvatori FM, De Santis A, Cerini F, Farcomeni A, Attili AF, Merli M.

Am J Gastroenterol. 2008 Nov;103(11):2738-46. doi: 10.1111/j.1572-0241.2008.02102.x. Epub 2008 Sep 4.

PMID:
18775022
10.

Relationship between pre-TIPS hepatic hemodynamics and postoperative incidence of hepatic encephalopathy.

Deng D, Liao MS, Qin JP, Li XA.

Hepatobiliary Pancreat Dis Int. 2006 May;5(2):232-6.

PMID:
16698582
11.

Efficacy of transjugular intrahepatic portosystemic shunt with adjunctive embolotherapy with cyanoacrylate for esophageal variceal bleeding.

Shi Y, Tian X, Hu J, Zhang J, Zhang C, Yang Y, Qin C.

Dig Dis Sci. 2014 Sep;59(9):2325-32. doi: 10.1007/s10620-014-3150-2. Epub 2014 Apr 19.

PMID:
24748182
12.

Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy + β-blocker for prevention of variceal rebleeding.

Holster IL, Tjwa ET, Moelker A, Wils A, Hansen BE, Vermeijden JR, Scholten P, van Hoek B, Nicolai JJ, Kuipers EJ, Pattynama PM, van Buuren HR.

Hepatology. 2016 Feb;63(2):581-9. doi: 10.1002/hep.28318. Epub 2015 Dec 28.

PMID:
26517576
13.

Urgent transjugular intrahepatic portosystemic shunt for control of acute variceal bleeding.

Bañares R, Casado M, Rodríguez-Láiz JM, Camúñez F, Matilla A, Echenagusía A, Simó G, Piqueras B, Clemente G, Cos E.

Am J Gastroenterol. 1998 Jan;93(1):75-9.

PMID:
9448179
14.

Endoscopic variceal ligation plus propranolol vs. transjugular intrahepatic portosystemic stent shunt: a long-term randomized trial.

Sauer P, Hansmann J, Richter GM, Stremmel W, Stiehl A.

Endoscopy. 2002 Sep;34(9):690-7.

PMID:
12195325
15.

Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed.

Membreno F, Baez AL, Pandula R, Walser E, Lau DT.

J Gastroenterol Hepatol. 2005 Mar;20(3):474-81.

PMID:
15740494
16.
17.

Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding.

Sauer P, Theilmann L, Stremmel W, Benz C, Richter GM, Stiehl A.

Gastroenterology. 1997 Nov;113(5):1623-31.

PMID:
9352865
18.

Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study.

Riggio O, Masini A, Efrati C, Nicolao F, Angeloni S, Salvatori FM, Bezzi M, Attili AF, Merli M.

J Hepatol. 2005 May;42(5):674-9.

PMID:
15826716
19.

Risk Factors for Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Patients with Hepatocellular Carcinoma and Portal Hypertension.

Yao J, Zuo L, An G, Yue Z, Zhao H, Wang L, Liu F.

J Gastrointestin Liver Dis. 2015 Sep;24(3):301-7. doi: 10.15403/jgld.2014.1121.243.yao.

20.

Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations.

Nolte W, Wiltfang J, Schindler C, Münke H, Unterberg K, Zumhasch U, Figulla HR, Werner G, Hartmann H, Ramadori G.

Hepatology. 1998 Nov;28(5):1215-25.

PMID:
9794904

Supplemental Content

Support Center